Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-21
SponsorSheba Medical Center

About this trial

The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, six months, 1 year, and two years after the connection.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Medtronic 780G® hybrid closed loop

Treatment groups

No treatment groups listed

Sponsors and collaborators

Sheba Medical Center

Lead sponsor

Tel-Aviv Sourasky Medical Center

Collaborator

Maccabi Healthcare Services, Israel

Collaborator

Wolfson Medical Center

Collaborator

Assaf-Harofeh Medical Center

Collaborator